Is PFS still a relevant endpoint for first-line TKIs?
Date | 11 April 2018 |
Event | ELCC 2018 European Lung Cancer Congress |
Session | First line for oncogene addicted lung cancer |
Topics | Non-Small-Cell Lung Cancer, Locally Advanced Cancer Immunology and Immunotherapy Lung and other Thoracic Tumours |
Presenter | Suresh Ramalingam |
Authors |
S.S. Ramalingam
|